A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...

FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...

More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new ...

FDA nonmedical wearable health data devices providing general health info will not face regulation, clarifying guidance for ...

The U.S. Food and Drug Administration says it will ease regulatory requirements for certain consumer wearable health devices.

Martin Makary, commissioner of the Food and Drug Administration, on the push against ultra processed foods and added sugar, ...

Target action dates for drugs sponsored by Sanofi, Boehringer Ingelheim and Disc Medicine have also been pushed back despite ...

The U.S. Food and Drug Administration may soon convert an entire generation of U.S. children, especially children in foster ...

FDA announces wearable devices providing non-medical info won't face regulation, offering clarity on digital health ...

The FDA will ease regulation of digital health products, aiming to deregulate AI and promote its widespread use.

Internal FDA reviews examined in the JAMA study show that the agency repeatedly confirmed that mifepristone is safe. One ...